Your browser doesn't support javascript.
loading
Interferon-γ resistance and immune evasion in glioma develop via Notch-regulated co-evolution of malignant and immune cells.
Parmigiani, Elena; Ivanek, Robert; Rolando, Chiara; Hafen, Katrin; Turchinovich, Gleb; Lehmann, Frank Michael; Gerber, Alexandra; Brkic, Sime; Frank, Stephan; Meyer, Sara C; Wakimoto, Hiroaki; Günel, Murat; Louvi, Angeliki; Mariani, Luigi; Finke, Daniela; Holländer, Georg; Hutter, Gregor; Tussiwand, Roxane; Taylor, Verdon; Giachino, Claudio.
Afiliação
  • Parmigiani E; Embryology and Stem Cell Biology, Department of Biomedicine, University of Basel, Mattenstrasse 28, 4058 Basel, Switzerland.
  • Ivanek R; Swiss Institute of Bioinformatics, Hebelstrasse 20, 4031 Basel, Switzerland; Bioinformatics Core Facility, Department of Biomedicine, University of Basel, Hebelstrasse 20, 4031 Basel, Switzerland.
  • Rolando C; Embryology and Stem Cell Biology, Department of Biomedicine, University of Basel, Mattenstrasse 28, 4058 Basel, Switzerland.
  • Hafen K; Pediatric Immunology, Department of Biomedicine, University of Basel, Mattenstrasse 28, 4058 Basel, Switzerland.
  • Turchinovich G; Developmental Immunology, Department of Biomedicine, University of Basel, Mattenstrasse 28, 4058 Basel, Switzerland; University Children's Hospital of Basel, University of Basel, Spitalstrasse 33, 4056, Basel, Switzerland.
  • Lehmann FM; Developmental Immunology, Department of Biomedicine, University of Basel, Mattenstrasse 28, 4058 Basel, Switzerland; University Children's Hospital of Basel, University of Basel, Spitalstrasse 33, 4056, Basel, Switzerland.
  • Gerber A; Brain Tumor Immunotherapy, Department of Biomedicine, University of Basel, Hebelstrasse 20, 4031 Basel, Switzerland.
  • Brkic S; Department of Biomedicine, University Hospital Basel and University of Basel, Hebelstrasse 20, 4031 Basel, Switzerland.
  • Frank S; Division of Neuropathology, Institute of Pathology, University of Basel, Schoenbeinstrasse 40, 4031 Basel, Switzerland.
  • Meyer SC; Department of Biomedicine, University Hospital Basel and University of Basel, Hebelstrasse 20, 4031 Basel, Switzerland; Division of Hematology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.
  • Wakimoto H; Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
  • Günel M; Department of Neurosurgery, Yale School of Medicine, New Haven, CT 06520-8082, USA.
  • Louvi A; Department of Neurosurgery, Yale School of Medicine, New Haven, CT 06520-8082, USA.
  • Mariani L; Department of Neurosurgery, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.
  • Finke D; Developmental Immunology, Department of Biomedicine, University of Basel, Mattenstrasse 28, 4058 Basel, Switzerland; University Children's Hospital of Basel, University of Basel, Spitalstrasse 33, 4056, Basel, Switzerland.
  • Holländer G; Pediatric Immunology, Department of Biomedicine, University of Basel, Mattenstrasse 28, 4058 Basel, Switzerland; Weatherall Institute of Molecular Medicine and Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK; Department of Biosystems Science and Engineering, ETH Zurich, Mattenstr
  • Hutter G; Brain Tumor Immunotherapy, Department of Biomedicine, University of Basel, Hebelstrasse 20, 4031 Basel, Switzerland; Department of Neurosurgery, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.
  • Tussiwand R; Immune Regulation, Department of Biomedicine, University of Basel, Mattenstrasse 28, 4058 Basel, Switzerland.
  • Taylor V; Embryology and Stem Cell Biology, Department of Biomedicine, University of Basel, Mattenstrasse 28, 4058 Basel, Switzerland.
  • Giachino C; Embryology and Stem Cell Biology, Department of Biomedicine, University of Basel, Mattenstrasse 28, 4058 Basel, Switzerland. Electronic address: claudio.giachino@unibas.ch.
Dev Cell ; 57(15): 1847-1865.e9, 2022 08 08.
Article em En | MEDLINE | ID: mdl-35803280
ABSTRACT
Immune surveillance is critical to prevent tumorigenesis. Gliomas evade immune attack, but the underlying mechanisms remain poorly understood. We show that glioma cells can sustain growth independent of immune system constraint by reducing Notch signaling. Loss of Notch activity in a mouse model of glioma impairs MHC-I and cytokine expression and curtails the recruitment of anti-tumor immune cell populations in favor of immunosuppressive tumor-associated microglia/macrophages (TAMs). Depletion of T cells simulates Notch inhibition and facilitates tumor initiation. Furthermore, Notch-depleted glioma cells acquire resistance to interferon-γ and TAMs re-educating therapy. Decreased interferon response and cytokine expression by human and mouse glioma cells correlate with low Notch activity. These effects are paralleled by upregulation of oncogenes and downregulation of quiescence genes. Hence, suppression of Notch signaling enables gliomas to evade immune surveillance and increases aggressiveness. Our findings provide insights into how brain tumor cells shape their microenvironment to evade immune niche control.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioma Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Dev Cell Assunto da revista: EMBRIOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioma Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Dev Cell Assunto da revista: EMBRIOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça